Peer-reviewedCC BYAnnals of medicine
Development and validation of a metabolic syndrome-based nomogram to predict 1-year metastasis after radiotherapy in locally advanced nasopharyngeal carcinoma
- 1Department of Cancer Center, The Second Affiliated Hospital, Hengyang Medical School, University of South China , , ,
- 2State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center , ,
Related
- Estimating Individualized Survival Benefit of Consolidative Metastasis-Directed Radiotherapy Following Chemoimmunotherapy in Nasopharyngeal Carcinoma With Exclusive Distant Metastasis.
- Metastasis-directed therapy in addition to definitive locoregional radiotherapy for De novo metastatic nasopharyngeal carcinoma: a retrospective cohort study.
- Development and Temporal Validation of a Three-Metabolite Cerebrospinal Fluid Model for the Diagnosis of Leptomeningeal Metastasis from Solid Tumors
- Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma
- Machine learning prediction model for distant metastasis at diagnosis in pediatric neuroblastoma: development, interpretation, and temporal validation
BibTeX
@article{chen2026development,
title = {{Development and validation of a metabolic syndrome-based nomogram to predict 1-year metastasis after radiotherapy in locally advanced nasopharyngeal carcinoma}},
author = {Yanyu Chen and Hao Cheng and Changjun Xie and Ruimin He and Yaolin He and Haihui Xie and Aixin Li and Li Liang and Baiqi Wang and Yanhua Chen and Liqin Jiang and Yingqing Li and Ping Feng},
journal = {Annals of medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656660},
note = {CC BY},
}
RIS
TY - JOUR
TI - Development and validation of a metabolic syndrome-based nomogram to predict 1-year metastasis after radiotherapy in locally advanced nasopharyngeal carcinoma
AU - Yanyu Chen
AU - Hao Cheng
AU - Changjun Xie
AU - Ruimin He
AU - Yaolin He
AU - Haihui Xie
AU - Aixin Li
AU - Li Liang
AU - Baiqi Wang
AU - Yanhua Chen
AU - Liqin Jiang
AU - Yingqing Li
AU - Ping Feng
PY - 2026
DA - 2026/10/16
JO - Annals of medicine
UR - https://europepmc.org/article/PMC/PMC13656660
SN - 0785-3890
SN - 1365-2060
ER -